These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22670575)

  • 1. Folic acid functionalized nanoparticles for enhanced oral drug delivery.
    Roger E; Kalscheuer S; Kirtane A; Guru BR; Grill AE; Whittum-Hudson J; Panyam J
    Mol Pharm; 2012 Jul; 9(7):2103-10. PubMed ID: 22670575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-polyethyleneimine functionalized mesoporous carbon nanoparticles for enhancing oral bioavailability of paclitaxel.
    Wan L; Wang X; Zhu W; Zhang C; Song A; Sun C; Jiang T; Wang S
    Int J Pharm; 2015 Apr; 484(1-2):207-17. PubMed ID: 25724138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity.
    Siu FY; Ye S; Lin H; Li S
    Int J Nanomedicine; 2018; 13():4133-4144. PubMed ID: 30038494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeation of PLGA nanoparticles across different in vitro models.
    Nkabinde LA; Shoba-Zikhali LN; Semete-Makokotlela B; Kalombo L; Swai HS; Hayeshi R; Naicker B; Hillie TK; Hamman JH
    Curr Drug Deliv; 2012 Nov; 9(6):617-27. PubMed ID: 22812395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
    Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
    J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.
    Fonseca C; Simões S; Gaspar R
    J Control Release; 2002 Oct; 83(2):273-286. PubMed ID: 12363453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
    Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
    J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.
    Joshi G; Kumar A; Sawant K
    Eur J Pharm Sci; 2014 Aug; 60():80-9. PubMed ID: 24810394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Assembled Core-Shell-Type Lipid-Polymer Hybrid Nanoparticles: Intracellular Trafficking and Relevance for Oral Absorption.
    Li Q; Xia D; Tao J; Shen A; He Y; Gan Y; Wang C
    J Pharm Sci; 2017 Oct; 106(10):3120-3130. PubMed ID: 28559042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
    Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
    Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cotransporting Ion is a Trigger for Cellular Endocytosis of Transporter-Targeting Nanoparticles: A Case Study of High-Efficiency SLC22A5 (OCTN2)-Mediated Carnitine-Conjugated Nanoparticles for Oral Delivery of Therapeutic Drugs.
    Kou L; Yao Q; Sun M; Wu C; Wang J; Luo Q; Wang G; Du Y; Fu Q; Wang J; He Z; Ganapathy V; Sun J
    Adv Healthc Mater; 2017 Sep; 6(17):. PubMed ID: 28661032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: In vitro and in vivo evaluation.
    Wang J; Li L; Wu L; Sun B; Du Y; Sun J; Wang Y; Fu Q; Zhang P; He Z
    Eur J Pharm Sci; 2017 Mar; 99():185-192. PubMed ID: 27989702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.
    Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S
    Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.
    Su WP; Cheng FY; Shieh DB; Yeh CS; Su WC
    Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.
    Joshi G; Kumar A; Sawant K
    Drug Deliv; 2016 Nov; 23(9):3492-3504. PubMed ID: 27297453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
    Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticulate formulations for paclitaxel delivery across MDCK cell monolayer.
    Xie J; Lei C; Hu Y; Gay GK; Bin Jamali NH; Wang CH
    Curr Pharm Des; 2010 Jul; 16(21):2331-40. PubMed ID: 20618154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.
    Le Broc-Ryckewaert D; Carpentier R; Lipka E; Daher S; Vaccher C; Betbeder D; Furman C
    Int J Pharm; 2013 Oct; 454(2):712-9. PubMed ID: 23707251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.